Modulation of myeloid differentation primary response gene 88 (Myd88) expression by antisense oligonucleotides
Details for Australian Patent Application No. 2009279524 (hide)
International Classifications
Event Publications
3 February 2011 Amendment Made
The nature of the amendment is: Amend the invention title to read Modulation of myeloid differentiation primary response gene 88 (MYD88) expression by antisense oligonucleotides 2010
3 February 2011 PCT application entered the National Phase
PCT publication WO2010/017436 Priority application(s): WO2010/017436
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser